Release of the 2021 Annual Report
(revised version after Shareholder's Meeting)
Date of events
2022/08/10
To which item it meets
paragraph 50
Statement
1.Date of receipt of letter from TPEx to request
supplement or correction:2022/08/08
2.Deadline imposed for supplement or correction:2022/08/11
3.Content of supplement or correction:Contents on pages 18、20、50、152、
and 153 of the 2021 Annual Report.
4.Countermeasures: Announce material information, and reupload the
revised annual report to MOPS.
5.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Arich Enterprise Co. Ltd. published this content on 10 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2022 09:56:09 UTC.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
